thumbnail image
  • HOME
  • OUR PHILOSOPHY & THESIS
  • TEAM
  • PORTFOLIO
  • NEWS
  • RESOURCES 
    • Term Sheet
    • Blog
    • pi Fellows Sessions
    • #chAI
    • DeepTech Shifts 2026
  • …  
    • HOME
    • OUR PHILOSOPHY & THESIS
    • TEAM
    • PORTFOLIO
    • NEWS
    • RESOURCES 
      • Term Sheet
      • Blog
      • pi Fellows Sessions
      • #chAI
      • DeepTech Shifts 2026
    • HOME
    • OUR PHILOSOPHY & THESIS
    • TEAM
    • PORTFOLIO
    • NEWS
    • RESOURCES 
      • Term Sheet
      • Blog
      • pi Fellows Sessions
      • #chAI
      • DeepTech Shifts 2026
    • …  
      • HOME
      • OUR PHILOSOPHY & THESIS
      • TEAM
      • PORTFOLIO
      • NEWS
      • RESOURCES 
        • Term Sheet
        • Blog
        • pi Fellows Sessions
        • #chAI
        • DeepTech Shifts 2026
      • pi Ventures has been recognized by the CDC Group as a "2X Challenge" Fund, as 42% of our portfolio companies (Niramai, Wysa, Pyxis, TrueLark, and Transper) have at least one woman co-founder.
         
        Although we do not focus on gender composition while making investment decisions, we have come across a significant number of high-growth potential DeepTech companies, which are being led by women entrepreneurs.
         
        The 2X Challenge was originally launched in 2018, and has been renewed in 2021 as a commitment to ‘gender-smart investing’ by a group of international Development Finance Institutions (DFIs) of the G7 and Multilateral Development Banks (MDBs), including CDC. The group aims to collectively mobilize $3 billion in commitments that provide women in developing countries with improved access to leadership opportunities, quality employment, finance, enterprise support & products, and services that meaningfully support women. The 2X Challenge aims to identify eligible businesses that are committed to one or more of these areas.
        Know More About 2X Challenge

      © 2021

      All Posts
      ×
      Cookie Use
      We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
      Learn More